A new study has shown that rapid and point-of-care hepatitis C tests are highly accurate and reliable, with accuracy rates ranging from 97 to 99%. These tests have the potential to transform global screening practices and improve treatment outcomes for millions of infected individuals worldwide.
A Montreal-based research team has identified genetic patterns in ovarian cancer tumors that relate to patient survival after initial surgery. The study found that patients with mutant p53 protein had longer survival rates compared to those without.
The Canadian Longitudinal Study on Aging (CLSA) is a comprehensive study on aging that will investigate factors affecting health and quality of life in Canadians. The Montreal component, launched by the Research Institute of McGill University Health Centre, will collect data from 3,000 people between ages 45-85 for a 20-year period.
A team of scientists identified a gene that is vital to the transport of vitamin into cells, leading to early diagnosis and potential treatment for a rare genetic disorder. The discovery sheds light on how vitamin B12 functions in the body.
A study at McGill University Health Centre found that caffeine improved motor symptoms in people with Parkinson's disease by increasing speed of movement and reducing stiffness. Larger-scale studies are needed to confirm these findings and explore caffeine as a treatment option.
A team of international scientists has identified the new gene responsible for Leber Congenital Amaurosis (LCA), a devastating genetic form of blindness in newborns. NMNAT1 is crucial for life and produces a vital coenzyme called NAD, involved in hundreds of reactions in the cell.
A new ethics framework is recommended to manage conflicts of interest in the development of medical guidelines, ensuring expert input without industry influence. The study found that such a framework can help identify and address ethics issues, but further analysis and initiatives are needed.
A new study published in JAMA found that elderly women with atrial fibrillation are at a higher risk of stroke than men. The study suggests that these women may need more effective stroke prevention therapy, which could be targeted towards female sex as a key risk factor.
A Canadian-led research team has identified two genetic mutations responsible for up to 40% of glioblastomas in children, a fatal cancer of the brain. The mutations were found to be involved in DNA regulation, which could explain resistance to traditional treatments and have significant implications on other cancers.
A saliva test used to diagnose HIV has been found to be comparable in accuracy to the traditional blood test, according to a new study. The test showed high sensitivity and specificity rates of 99% and 97%, respectively, making it a promising tool for HIV diagnosis, particularly in high-risk populations.
Elderly patients who visit emergency departments are three times more likely to develop respiratory or gastrointestinal infections after returning to a long-term care facility. Isolating residents for 7 days following an ED visit can help prevent outbreaks and reduce the financial burden on healthcare facilities.
Researchers at McGill University Health Centre have developed a novel melatonin drug, UCM765, that selectively activates the MT2 receptor in the brain, leading to increased phases of deep sleep. This discovery may pave the way for effective treatments for insomnia, a common public health problem affecting millions worldwide.
Researchers at McGill University Health Centre have identified parathyroid hormone-related protein (PTHrP) as a key player in breast cancer progression and metastasis. The study found that blocking PTHrP production can reduce tumor growth by 80-90% and prevent its spread to other organs.
A study by McGill University Health Centre researchers found that adolescent amphetamine use can cause neurobiological imbalances and increase risk-taking behavior, effects that persist into adulthood. The study used animal models and found abnormalities in key neurotransmitters serotonin, dopamine, and norepinephrine.
The Research Institute of the McGill University Health Centre (RI-MUHC) has been awarded a $1.4M grant to develop Personalized Medicine for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH). The project aims to identify new biomarkers and disease predictors to improve diagnosis and treatment options.
A decade-long study demonstrates that holmium laser therapy is a safe and durable treatment option for Benign Prostatic Hyperplasia, reducing complications and recurrence rates compared to traditional TURP. Patients treated with HoLEP experience reduced pain, shorter hospital stays, and fewer sexual side effects.
A new blood test has been developed to diagnose Alzheimer's disease at an early stage using biochemical analysis of dehydroepiandrosterone (DHEA) production. The test was able to accurately detect the disease with small samples of blood and differentiate it from other types of dementia.
A new study found that naltrexone, a medication for alcohol dependence, is more effective in women and those with a specific genetic variation. This discovery could lead to personalized medicine and improved treatment outcomes for patients.
A study by McGill University Health Centre researchers highlights the need for a comprehensive electronic health record system to improve chronic disease management and timely access to care. The authors suggest that more work is needed to address implementation challenges and ensure successful adoption of e-health technologies.
Researchers at McGill University Health Centre solved two cold cases using genetic studies, identifying a gene responsible for rare cancer and thyroid disease. The findings provided answers for families affected by the diseases, including information on screening tests and risk for future generations.
A recent study by McGill University Health Centre demonstrates that single-patient rooms in Intensive Care Units (ICU) significantly reduce the acquisition of infections such as C-difficile, Staphylococcus aureus and Enterococcus. The results show a 50% reduction in infection rates and a 10% decrease in length of stay.
Research led by McGill University Health Centre found that nearly 70% of parents reported feeling closer to their babies after reading to them in the NICU. The practice also encouraged parents to continue reading at home, with those who read to their child in the NICU three times more likely to do so.
A new Montreal study suggests a link between air pollution from traffic and an increased risk of post-menopausal breast cancer. The study found that women living in areas with high levels of nitrogen dioxide, a by-product of vehicular traffic, were more likely to develop breast cancer.
A new study published in the Canadian Medical Association Journal finds that low doses of inhaled cannabis containing THC offer modest pain reduction and improved moods in patients with chronic neuropathic pain. The study suggests that medical cannabis may be a viable alternative for patients who have not responded to standard therapies.
A research team at McGill University Health Centre has developed a rapid genome sequencing process to identify genetic diseases, promising personalized treatments for patients. The new approach can isolate genes responsible for hereditary diseases within two weeks, revolutionizing the screening and treatment of genetic disorders.
A team of researchers from McGill/MUHC has developed a novel screening tool to diagnose Chagas disease, a parasitic disease affecting over 10 million people in the Americas. The new approach uses mass spectrometry technology to identify specific biological markers left by the parasite, enabling rapid and reliable diagnosis.
CanCOLD is a nationwide study to understand Chronic Obstructive Pulmonary Disease (COPD), improving its management and reducing its burden. The MUHC leads the pan-Canadian initiative, which aims to demystify COPD and improve public awareness.
A new study reveals that regulating intestinal inflammation can prevent colon cancer by controlling the activity of two proteins, Caspase-1 and Caspase-12. Caspase-1 plays a crucial role in maintaining the intestinal barrier, while its absence leads to uncontrolled cell proliferation and increased risk of colorectal cancer.
A recent study by Dr. Richard Kremer found that nearly 60% of healthy young women had insufficient vitamin D levels, leading to increased body fat and decreased muscle strength. The research highlights the importance of vitamin D in maintaining overall health and suggests a potential link between low vitamin D levels and various diseases.
The Canadian Institutes of Health Research has awarded Medicago a $300,000 grant to study the immune response induced by VLPs. The research aims to develop leading plant-based VLP vaccines with potential benefits for global health, particularly in the developing world.
Two research teams from McGill University Health Centre and McGill University will analyze the effects of brominated flame retardants and phthalates on human reproduction. The five-year study aims to understand the mechanisms underlying these substances' toxicity and their potential impact on future generations.
A new study published in Journal of Biological Chemistry found that Vitamin D deficiency can contribute to Crohn's disease. The researchers discovered that Vitamin D acts directly on genes involved in fighting intestinal bacteria and immune responses. Siblings of patients with Crohn's disease may benefit from ensuring they are vitamin ...
Scientists at MUHC and international colleagues discovered a chromosomal site controlling natural resistance to TB infection, found in 20% of individuals from high-exposure areas. The findings hold promise for preventing TB infection in the general population by stimulating resistance mechanisms.
McGill University Health Centre researchers have developed an innovative immunotherapy customized for each patient, showing immense promise in combating HIV/AIDS. The therapy uses dendritic cells to target specific viral strains, resulting in increased levels of CD8-lymphocytes and few reported side effects.
A study published in PLoS One highlights the poor quality of diagnostic tests for TB, malaria, and HIV commercial tests, citing moderate to low quality studies with poorly reported methodologies. The researchers emphasize the need for improved test assessment to prevent incorrect diagnoses and adverse consequences.
A recent study published in the Journal of Rheumatology has found a clear link between smoking and skin problems in people with systemic lupus erythematosus (SLE). The study, led by Dr. Christian A Pineau, reveals that smokers are at higher risk for skin damage, including permanent hair loss and scarring from skin inflammation.
A team of researchers found that interleukin-2 has no effect on the development of AIDS or patient survival. The study, involving over 5000 patients in 25 countries, suggests that IL-2 treatment provides no benefit and does not prevent AIDS-related infectious diseases.
Researchers at McGill University Health Centre discovered a key molecule, GP63 protease, that neutralizes macrophages' defences and hinders the body's innate inflammatory immune response. The study provides a promising approach to treating leishmania as well as other infectious diseases.
A new study by Dr. Nitika Pant Pai found that only 15% of HIV-positive repeat offenders in San Francisco County jail continued their antiretroviral treatment between incarcerations or after release, increasing the risk of disease progression and public health transmission.
A recent study by MUHC/McGill researchers suggests that tuberculosis treatment guidelines should be revised, recommending extended treatment periods for new cases and more effective combinations of drugs to avoid drug resistance. The World Health Organization is urged to review its directives to benefit the global community
Patients with polymyositis and dermatomyositis, autoimmune disorders causing muscle inflammation, are at higher risk of developing cardiovascular disease. The study found that immunosuppressive therapies may have a preventive effect against heart attacks, providing hope for patients hesitant to undergo treatment.
Researchers at McGill University Health Centre have discovered the mechanism by which hemozoin activates the immune system, leading to inflammation and fever in malaria patients. The study provides a new direction for developing vaccine-like treatments to limit the severity of the disease.
A recent study by Dr. Basil Petrof reveals that the CFTR gene is involved in calcium regulation in skeletal muscles, contributing to muscle atrophy and weakness in cystic fibrosis patients. The research also suggests that controlling inflammation and infection may be key to treating CF-related muscle atrophy.
A study has found that a mutation in the NOD2 gene may predispose individuals to Crohn's disease by impairing the immune system's ability to recognize and fight off mycobacteria. The research, published in the Journal of Experimental Medicine, highlights the potential for new therapeutic approaches to combat the disease.
A new study by Dr. Thao Huynh analyzes the best way to treat patients with heart attacks, suggesting that reducing delays in providing primary PCI can maximize its effectiveness. The study also highlights the importance of optimal medical therapy after discharge to prevent repeat heart attacks.
A team of Canadian and American researchers have identified a way to treat HIV-AIDS by targeting both viruses in the body and those hiding in immune system cells. This breakthrough opens the door for innovative therapies that differ from current approaches.
Dr. Maya Saleh will investigate the regulation and molecular mechanisms of NLR-mediated innate immunity using a six-year grant from the Burroughs Wellcome Fund. The goal is to identify genes needed for defense against infections, shedding light on human host interactions with infectious agents.
A study published in the New England Journal of Medicine suggests that cigarette smoking does not affect everyone in the same way, with some people experiencing severe breathing difficulties while others evade the disease. The research proposes an autoimmune mechanism compounded by genetic predisposition as a possible explanation for t...
The study reveals an average waiting time of 5 years for bariatric surgery in Canada, a significantly longer timeframe compared to other surgical procedures. Bariatric surgery has been shown to reduce the risk of death by up to 85% and can save lives.
An international collaboration has made identifying crucial proteins in diseases easier through improved protein analysis. The study, published in Nature Methods, reveals potential bottlenecks in current analysis techniques and highlights the importance of accurate reporting.